Skip to main content

48 publications

Name Date Type Actions

2016 calendar of financial communication

December 15, 2015 (Lure, France) – Vétoquinol published its calendar of financial communication for 2016.

15/12/2015 Agenda

0 pages

Monthly information regarding the total number of voting rights and shares making of the share capital - November 2015

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

04/12/2015 Voting rights

0 pages

Programme de rachat - novembre 2015 (french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres

04/12/2015 Monthly communication regarding buyback programs

0 pages

Vetoquinol et nippon Zenyaku Kogyo Co. ltd. signent un accord de joint-venture au Japon

Vetoquinol and Nippon Zenyaku Kogyo Co., Ltd., also operating under the trade name “Zenoaq”, announced today the signature of a joint-venture agreement to develop, register and market a range of animal health products in Japan.

03/12/2015 Public releases

0 pages

Monthly information regarding the total number of voting rights and shares making of the share capital - Octobre 2015

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

05/11/2015 Voting rights

0 pages

Programme de rachat - octobre 2015 (french)

Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres

05/11/2015 Monthly communication regarding buyback programs

0 pages

September 2015 year-to-date sales up 8.7% to €251.8 million

Vetoquinol sales for the first nine months of 2015 rose 8.7% to €251.8 million, boosted by a positive currency impact of €13.7 million. Organic growth for the same period came to 0.7%.

22/10/2015 Public releases

0 pages

Monthly information regarding the total number of voting rights and shares making of the share capital - September 2015

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

05/10/2015 Voting rights

0 pages

Programme de rachat - septembre 2015 (french)

Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres

05/10/2015 Monthly communication regarding buyback programs

0 pages

VETOQUINOL launches UPCARD©, an innovative drug for congestive heart failure in dogs

Vétoquinol continues the deployment of its reference products with the European launch of UPCARD©, an innovative drug designed to treat congestive heart failure in dogs.

14/09/2015 Public releases

0 pages